Vax-Before-Travel
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Appointments
Destinations
Discounts
News
Outbreaks
Vaccines
ABRYSVO RSVpreF RSV Vaccine
ABRYSVO RSVpreF RSV Vaccine
Fact checked by
Robert Carlson, MD
Oct 8
3 min read
RSV Vaccine Candidate Produced 10-20 Fold Increase in Virus-Killing Antibodies
RSVpreF vaccine candidate has the potential to prevent Respiratory Syncytial Virus disease in infants by immunizing pregnant women
Respiratory Syncytial Virus (RSV)
